Free Newsletter
Expert panel cites researcher for faking data
An expert panel formed by the University of Minnesota has determined that a PhD student who worked with a team of researchers responsible for a high-profile study involving adult stem cells extracted from bone marrow falsified data in an earlier research report. New Scientist reports that it raised questions about irregularities in the team's 2002 report led by Catherine Verfaillie. The group had reported seeing extraordinary versatility in the adult stem cell, a conclusion that gained widespread attention.
New Scientist reported last year that figures and images in the report had been manipulated. The university panel confirmed images had been manipulated and asked that the paper be retracted. But the panel also concluded that there was insufficient evidence to conclude that the team had engaged in misconduct.
- read the report from New Scientist
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




